Breast cancer and pregnancy

Seminars in Oncology

Volumn 27, Issue 6, 2000, Pages 646-653

  Moore, H C F ^a   Foster R S , Jr ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST CARCINOGENESIS; BREAST FEEDING; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RISK; FEMALE; FEMALE FERTILITY; HUMAN; MEDICAL DECISION MAKING; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL EXPOSURE DELAYED EFFECTS; PROGNOSIS; RISK FACTORS;

EID: 0033635685     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Cancer in pregnancy: A review of the literature
2. Pregnancy poses tough questions for cancer treatment
3. Etiology of human breast cancer. A review
4. Reproductive and hormonal risk factors Reproductive factors and breast cancer
5. The short-term and long-term effect of a pregnancy on breast cancer risk. A prospective study of 802,457 parous Norwegian women
6. Transient increase in the risk of breast cancer after giving birth
7. Cancers coinciding with childbearing Delayed diagnosis during pregnancy
8. Breast disease complicating pregnancy
9. Surgical management of breast masses in pregnant women
10. Imaging of pregnancy-associated breast cancer
11. Breast cancer during pregnancy
12. Treatment of breast tumors associated with pregnancy and lactation
13. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation Analysis of case-control study in Japan
14. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis
15. Influence of pregnancy on the outcome of breast cancer: A case-control study
16. Maternal and fetal outcome after breast cancer in pregnancy
17. Breast cancer and pregnancy
18. Breast cancer during pregnancy. Quantifying the risk of treatment delay
19. Delayed diagnosis of breast cancer as a result of normal mammograms
20. Management of breast cancer during pregnancy using a standardized protocol
21. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients
22. Prognosis of pregnancy-associated breast cancer
23. Breast cancer associated with pregnancy or lactation
24. The pregnant surgical patient: Medical evaluation and management
25. Fetal dose evaluation during breast cancer radiotherapy
26. Radiation therapy during pregnancy
27. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control
28. Analysis of outcomes for high risk breast cancer patients based on interval from surgery to postmastectomy radiation therapy
29. Antineoplastic agents and pregnancy
30. Anthracyclines in the treatment of malignancy in pregnancy
31. Improved disease-free survival (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (PTS) with node-positive primary breast cancer (BC)
32. A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer
33. Placental metastases in a patient with recurrent breast carcinoma
34. Long-term follow-up of children exposed in utero to antineoplastic agents
35. Acute leukemia during pregnancy The Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents
36. Risk of cancer among offspring of childhood-cancer survivors
37. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients
38. Influence of prior and subsequent pregnancy on breast cancer prognosis
39. Should women be advised against pregnancy after breast-cancer treatment
40. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer